Caricamento...
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
INTRODUCTION: Eosinophilic granulomatosis with polyangiitis (EGPA) is a subset of antineutrophil cytoplasmic antibodies (ANCA) associated vasculitis with distinct pathophysiological mechanisms, clinical features and treatment responses. Rituximab is a licensed therapy for granulomatosis with polyang...
Salvato in:
| Pubblicato in: | RMD Open |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560673/ https://ncbi.nlm.nih.gov/pubmed/31245051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000905 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|